Bryan Williams

155.6k total citations · 24 hit papers
906 papers, 61.1k citations indexed

About

Bryan Williams is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Bryan Williams has authored 906 papers receiving a total of 61.1k indexed citations (citations by other indexed papers that have themselves been cited), including 271 papers in Cardiology and Cardiovascular Medicine, 257 papers in Molecular Biology and 186 papers in Immunology. Recurrent topics in Bryan Williams's work include Blood Pressure and Hypertension Studies (202 papers), interferon and immune responses (98 papers) and RNA regulation and disease (80 papers). Bryan Williams is often cited by papers focused on Blood Pressure and Hypertension Studies (202 papers), interferon and immune responses (98 papers) and RNA regulation and disease (80 papers). Bryan Williams collaborates with scholars based in United Kingdom, United States and Australia. Bryan Williams's co-authors include Robert H. Silverman, Ian M. Kerr, George R. Stark, Robert D. Schreiber, Sandy D. Der, Jonathan M. Nichols, Neil R Poulter, Aimin Zhou, Giuseppe Mancia and Simon Thom and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Bryan Williams

876 papers receiving 58.9k citations

Hit Papers

HOW CELLS RESPOND TO INTERFERONS 1990 2026 2002 2014 1998 2020 2006 1998 2014 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HOW CELLS RESPOND TO INTERFERONS
    1998 3.3k citations Bryan Williams, Robert H. Silverman et al. profile →
  2. 2020 International Society of Hypertension Global Hypertension Practice Guidelines
    2020 2.3k citations Fadi J. Charchar, Nadia Khan et al. Hypertension profile →
  3. Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes
    2006 1.7k citations Bryan Williams, Peter Lacy et al. Circulation profile →
  4. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays
    1998 1.5k citations Sandy D. Der, Aimin Zhou et al. profile →
  5. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
    2014 1.2k citations Bryan Williams et al. profile →
  6. Activation of the interferon system by short-interfering RNAs
    2003 1.1k citations Robert H. Silverman, Bryan Williams et al. profile →
  7. Monitoring for conservation
    2006 932 citations Bryan Williams et al. profile →
  8. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
    2004 872 citations Bryan Williams, Simon Thom et al. profile →
  9. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon
    1990 856 citations Bryan Williams et al. profile →
  10. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
    1998 767 citations Bryan Williams et al. profile →
  11. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
    2015 735 citations Bryan Williams, Thomas M. MacDonald et al. profile →
  12. Functional classification of interferon-stimulated genes identified using microarrays
    2001 715 citations Robert H. Silverman, Bryan Williams et al. profile →
  13. 2020 International Society of Hypertension global hypertension practice guidelines
    2020 713 citations Fadi J. Charchar, Nadia Khan et al. Journal of Hypertension profile →
  14. Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes
    2009 692 citations Sophia Zoungas, Anushka Patel et al. profile →
  15. TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages
    2002 685 citations Bryan Williams et al. profile →
  16. Artificial intelligence in healthcare: transforming the practice of medicine
    2021 668 citations Bryan Williams et al. profile →
  17. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary
    2004 591 citations Bryan Williams, Neil R Poulter et al. profile →
  18. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.
    1995 555 citations Bryan Williams et al. profile →
  19. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials
    2006 525 citations Bryan Williams et al. Journal of Hypertension profile →
  20. Essential hypertension
    2007 508 citations Bryan Williams et al. profile →
  21. Central Blood Pressure Measurements and Antihypertensive Therapy
    2007 474 citations Giuseppe Mancia, Bryan Williams et al. Hypertension profile →
  22. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study
    2020 330 citations Bryan Williams et al. profile →
  23. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
    2019 215 citations Bryan Williams et al. profile →
  24. Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients
    2023 139 citations Natalie Staplin, Alejandro de la Sierra et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan Williams United Kingdom 114 17.9k 17.8k 14.8k 6.9k 6.2k 906 61.1k
Giuseppe Remuzzi Italy 144 16.0k 0.9× 17.9k 1.0× 17.9k 1.2× 4.6k 0.7× 5.7k 0.9× 1.3k 95.1k
Christian Weber Germany 131 22.5k 1.3× 8.0k 0.4× 22.5k 1.5× 8.9k 1.3× 7.5k 1.2× 1.1k 69.1k
Russell Ross United States 110 25.1k 1.4× 13.3k 0.7× 17.6k 1.2× 5.7k 0.8× 9.9k 1.6× 245 79.4k
Aldons J. Lusis United States 116 30.8k 1.7× 6.3k 0.4× 10.5k 0.7× 3.4k 0.5× 6.8k 1.1× 617 63.9k
Nader Rifai United States 122 9.2k 0.5× 21.5k 1.2× 9.1k 0.6× 4.5k 0.6× 21.7k 3.5× 455 77.6k
Steve E. Humphries United Kingdom 94 7.9k 0.4× 10.0k 0.6× 4.2k 0.3× 2.2k 0.3× 6.0k 1.0× 872 42.3k
David J. Gordon United States 73 7.6k 0.4× 6.3k 0.4× 3.2k 0.2× 2.1k 0.3× 4.8k 0.8× 231 32.8k
Richard Peto United Kingdom 108 7.5k 0.4× 13.8k 0.8× 2.2k 0.1× 11.2k 1.6× 7.8k 1.3× 300 75.8k
Richard J. Johnson United States 136 15.6k 0.9× 5.8k 0.3× 4.1k 0.3× 1.8k 0.3× 14.1k 2.3× 815 68.9k
Yehuda Shoenfeld Israel 115 8.2k 0.5× 3.1k 0.2× 20.2k 1.4× 3.0k 0.4× 7.9k 1.3× 1.6k 63.1k

Countries citing papers authored by Bryan Williams

Since Specialization
Citations

This map shows the geographic impact of Bryan Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Williams more than expected).

Fields of papers citing papers by Bryan Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Williams. The network helps show where Bryan Williams may publish in the future.

Co-authorship network of co-authors of Bryan Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan Williams. A scholar is included among the top collaborators of Bryan Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan Williams. Bryan Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Böhm, Michael, Alejandro de la Sierra, Felix Mahfoud, et al.. (2024). Office measurement vs. ambulatory blood pressure monitoring: associations with mortality in patients with or without diabetes. European Heart Journal. 45(31). 2851–2861. 3 indexed citations
2.
Sierra, Alejandro de la, Luís M. Ruilope, Natalie Staplin, George S. Stergiou, & Bryan Williams. (2024). Mortality risks in different subtypes of masked hypertension in the Spanish ambulatory blood pressure monitoring registry. Journal of Hypertension. 43(4). 642–648. 3 indexed citations
3.
Williams, Bryan, et al.. (2022). Metastatic Melanoma to a Neurofibroma.. PubMed. 44(9). 683–686. 2 indexed citations
4.
5.
Xu, Xiaoguang, James Eales, Xiao Jiang, et al.. (2021). Contributions of obesity to kidney health and disease: insights from Mendelian randomization and the human kidney transcriptomics. Cardiovascular Research. 118(15). 3151–3161. 22 indexed citations
6.
Jozwiak, Jacek Jerzy, Tomasz Tomasik, Adam Windak, et al.. (2020). The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study. Atherosclerosis Supplements. 42. e15–e24. 18 indexed citations
7.
Ohkuma, Toshiaki, Mark Woodward, Min Jun, et al.. (2017). Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus. Hypertension. 70(2). 461–468. 58 indexed citations
8.
Chüeh, Anderly C., Janson W.T. Tse, Michael Dickinson, et al.. (2017). ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types. Clinical Cancer Research. 23(18). 5573–5584. 44 indexed citations
9.
Xu, Dakang, et al.. (2016). Activating Transcription Factor 3 Expression as a Marker of Response to the Histone Deacetylase Inhibitor Pracinostat. Molecular Cancer Therapeutics. 15(7). 1726–1739. 12 indexed citations
10.
Thompson, Matthew R., Dakang Xu, & Bryan Williams. (2013). Activating Transcription Factor 3 Contributes to Toll-Like Receptor-Mediated Macrophage Survival via Repression of Bax and Bak. Journal of Interferon & Cytokine Research. 33(11). 682–693. 9 indexed citations
11.
Hata, Jun, Hisatomi Arima, Peter M. Rothwell, et al.. (2013). Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus. Circulation. 128(12). 1325–1334. 163 indexed citations
12.
Yu, Liang, Junhua Li, Guohua Xie, et al.. (2013). ATF3 Suppresses Metastasis of Bladder Cancer by Regulating Gelsolin-Mediated Remodeling of the Actin Cytoskeleton. Cancer Research. 73(12). 3625–3637. 8 indexed citations
13.
Williams, Bryan, Peter Lacy, J. CRUICKSHANK, et al.. (2008). Impact of Statin Therapy on Central Aortic Pressures and Hemodynamics. Circulation. 119(1). 53–61. 64 indexed citations
14.
Li, Wenliang, Patricia Kessler, Herman Yeger, et al.. (2005). A Gene Expression Signature for Relapse of Primary Wilms Tumors. Cancer Research. 65(7). 2592–2601. 46 indexed citations
15.
Dong, Beihua, Quansheng Zhou, Ji Zhao, et al.. (2004). Phospholipid Scramblase 1 Potentiates the Antiviral Activity of Interferon. Journal of Virology. 78(17). 8983–8993. 101 indexed citations
16.
Zheng, Shuo, Bishnu P. De, Suresh Choudhary, et al.. (2003). Impaired Innate Host Defense Causes Susceptibility to Respiratory Virus Infections in Cystic Fibrosis. Immunity. 18(5). 619–630. 94 indexed citations
17.
Lau, Allan S. Y., Sandy D. Der, Stanley Read, & Bryan Williams. (1991). Regulation of Tumor Necrosis Factor Receptor Expression by Acid-Labile Interferon-α from AIDS Sera. AIDS Research and Human Retroviruses. 7(6). 545–552. 21 indexed citations
18.
Williams, Bryan, P. Burton, J. Feehally, & John Walls. (1989). The Changing Face of End Stage Renal Disease in a UK Renal Unit. Journal of the Royal College of Physicians of London. 23(2). 116–120. 1 indexed citations
19.
Krause, Lisa, Bryan Williams, & Selwyn A. Broitman. (1980). Relationship of diet high in lipid and cholesterol on immune function in rats given 1,2,dimethylhydrazine (DMH).. American Journal of Clinical Nutrition. 33(4). 4 indexed citations
20.
Pepys, Mark B., et al.. (1978). Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 32(1). 119–24. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppe Remuzzi Breakdown of academic impact, for papers by Christian Weber Breakdown of academic impact, for papers by Russell Ross Breakdown of academic impact, for papers by Aldons J. Lusis Breakdown of academic impact, for papers by Nader Rifai Breakdown of academic impact, for papers by Steve E. Humphries Breakdown of academic impact, for papers by David J. Gordon Breakdown of academic impact, for papers by Richard Peto Breakdown of academic impact, for papers by Richard J. Johnson Breakdown of academic impact, for papers by Yehuda Shoenfeld
Rankless by CCL
2026